 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *sb0646*      
SENATE BILL 646  
J5, J4    5lr2852  
    CF HB 970  
By: Senator Muse  
Introduced and read first time: January 25, 2025  
Assigned to: Finance  
Committee Report: Favorable with amendments  
Senate action: Adopted  
Read second time: March 11, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Health Insurance – Insulin – Prohibition on Step Therapy or Fail –First 2 
Protocols  3 
 
FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health 4 
maintenance organizations from imposing a step therapy or fail –first protocol on 5 
insulin or certain other similar medications  or an insulin analog  used to treat an 6 
insured’s or enrollee’s diabetes; and generally relating to use of step therapy and 7 
fail–first protocols.  8 
 
BY repealing and reenacting, without amendments,  9 
 Article – Insurance  10 
Section 15 –142(a)(1) and (4) and (b)  11 
 Annotated Code of Maryland  12 
 (2017 Replacement Volume and 2024 Supplement)  13 
 
BY repealing and reenacting, with amendments,  14 
 Article – Insurance  15 
Section 15 –142(e)  16 
 Annotated Code of Maryland  17 
 (2017 Replacement Volume and 2024 Supplement)  18 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 19 
That the Laws of Maryland read as follows:  20 
 
Article – Insurance  21 
2 SENATE BILL 646   
 
  
15–142. 1 
 
 (a) (1) In this section the following words have the meanings indicated.  2 
 
  (4) (i) “Step therapy or fail –first protocol” means a protocol established 3 
by an insurer, a non profit health service plan, or a health maintenance organization that 4 
requires a prescription drug or sequence of prescription drugs to be used by an insured or 5 
an enrollee before a prescription drug ordered by a prescriber for the insured or the enrollee 6 
is covered.  7 
 
   (ii) “Step therapy or fail –first protocol” includes a protocol that 8 
meets the definition under subparagraph (i) of this paragraph regardless of the name, label, 9 
or terminology used by the insurer, nonprofit health service plan, or health ma intenance 10 
organization to identify the protocol.  11 
 
 (b) (1) This section applies to:  12 
 
   (i) insurers and nonprofit health service plans that provide hospital, 13 
medical, or surgical benefits to individuals or groups on an expense –incurred basis under 14 
health insurance policies or contracts that are issued or delivered in the State; and  15 
 
   (ii) health maintenance organizations that provide hospital, 16 
medical, or surgical benefits to individuals or groups under contracts that are issued or 17 
delivered in the State . 18 
 
  (2) An insurer, a nonprofit health service plan, or a health maintenance 19 
organization that provides coverage for prescription drugs through a pharmacy benefits 20 
manager is subject to the requirements of this section.  21 
 
 (e) An entity subject to this sec tion may not impose a step therapy or fail –first 22 
protocol on an insured or an enrollee for a prescription drug approved by the U.S. Food and 23 
Drug Administration if:  24 
 
  (1) (I) the prescription drug is used to treat the insured’s or enrollee’s 25 
stage four ad vanced metastatic cancer; and  26 
 
  [(2)] (II) use of the prescription drug is:  27 
 
   [(i)] 1. consistent with the U.S. Food and Drug  28 
Administration –approved indication or the National Comprehensive Cancer Network 29 
Drugs & Biologics Compendium indication for the treatment of stage four advanced 30 
metastatic cancer; and  31 
 
   [(ii)] 2. supported by peer –reviewed medical literature ; OR 32 
 
  (2) THE PRESCRIPTION DRU G IS:  33 
 SENATE BILL 646  3 
 
  
   (I) INSULIN OR AN INSULI N ANALOG  USED TO TREAT THE 1 
INSURED ’S OR ENROLLEE ’S TYPE 1, TYPE 2, OR GESTATIONAL DIABETES ; AND  2 
 
   (II) 1. INSULIN ; OR 3 
 
    2. AN INSULIN ANALOG OR  OTHER PRESCRIPTION D RUG  4 
THAT PERFORMS A SIMI LAR FUNCTION TO INSU LIN, REGARDLESS OF THE  5 
ACTIVATION PERIOD , WHETHER THE SOLUTION  IS MIXED BEFORE OR A FTER  6 
DISPENSING , OR WHETHER TH E DRUG IS ADMINISTER ED BY INJECTION OR  7 
INHALATION . 8 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 9 
policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 10 
after January 1, 2026.  11 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 12 
January 1, 2026.  13 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
                 President of the Senate.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  